[en] Background and Objectives: Ovarian tissue cryopreservation followed by autotransplantation (OTCTP) is currently the only fertility preservation option for prepubertal patients. Once in remission, the autotransplantation of frozen/thawed tissue is performed when patients want to conceive. A major issue of the procedure is follicular loss directly after grafting mainly due to follicle activation. To improve follicular survival during the OTCTP procedure, we inhibited the mTOR pathway involved in follicle activation using rapamycin, an mTOR inhibitor. Next, we compared two different in vivo models of transplantation: the recently described non-invasive heterotopic transplantation model between the skin layers of the ears, and the more conventional and invasive transplantation under the kidney capsule. Materials and Methods: To study the effects of adding rapamycin during cryopreservation, 4-week-old C57BL/6 mouse ovaries, either fresh, slow-frozen, or slow-frozen with rapamycin, were autotransplanted under the kidney capsule of mice and recovered three weeks later for immunohistochemical (IHC) analysis. To compare the ear with the kidney capsule transplantation model, fresh 4-week-old C57BL/6 mouse ovaries were autotransplanted to either site, followed by an injection of either LY294002, a PI3K inhibitor, vehicle control, or neither, and these were recovered three weeks later for IHC analysis. Results: Rapamycin counteracts cryopreservation-induced follicle proliferation, as well as AKT and mTOR pathway activation, in ovaries autotransplanted for three weeks under the kidney capsule of mice. Analyses of follicle proliferation, mTOR activation, and the effects of LY294002 treatment were similar in transplanted ovaries using either the ear or kidney capsule transplantation model. Conclusions: By adding rapamycin during the OTCTP procedure, we were able to transiently maintain primordial follicles in a quiescent state. This is a promising method for improving the longevity of the ovarian graft. Furthermore, both the ear and kidney capsule transplantation models were suitable for investigating follicle activation and proliferation and pharmacological strategies.
Disciplines :
Life sciences: Multidisciplinary, general & others
Author, co-author :
Bindels, Jules ; Université de Liège - ULiège > GIGA > GIGA Cancer - Tumours and development biology
Poorvu P.D. Frazier A.L. Feraco A.M. Manley P.E. Ginsburg E.S. Laufer M.R. LaCasce A.S. Diller L.R. Partridge A.H. Cancer Treatment-Related Infertility: A Critical Review of the Evidence JNCI Cancer Spectr. 2019 3 pkz008 10.1093/jncics/pkz008 31360893
Levine J.M. Kelvin J.F. Quinn G.P. Gracia C.R. Infertility in reproductive-age female cancer survivors Cancer 2015 121 1532 1539 10.1002/cncr.29181 25649243
Kim S. Lee Y. Lee S. Kim T. Ovarian tissue cryopreservation and transplantation in patients with cancer Obstet. Gynecol. Sci. 2018 61 431 442 10.5468/ogs.2018.61.4.431 30018897
Shapira M. Dolmans M.M. Silber S. Meirow D. Evaluation of ovarian tissue transplantation: Results from three clinical centers Fertil. Steril. 2020 114 388 397 10.1016/j.fertnstert.2020.03.037
Marin L. Bedoschi G. Kawahara T. Oktay K.H. History, Evolution and Current State of Ovarian Tissue Auto-Transplantation with Cryopreserved Tissue: A Successful Translational Research Journey from 1999 to 2020 Reprod. Sci. 2020 27 955 962 10.1007/s43032-019-00066-9
Fraison E. Huberlant S. Labrune E. Cavalieri M. Montagut M. Brugnon F. Courbiere B. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: A systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation Hum. Reprod. 2023 38 489 502 10.1093/humrep/deac249
Donnez J. Dolmans M.M. Fertility Preservation in Women N. Engl. J. Med. 2017 377 1657 1665 10.1056/NEJMra1614676
Dolmans M.M. Donnez J. Fertility preservation in women for medical and social reasons: Oocytes vs ovarian tissue Best Pract. Res. Clin. Obstet. Gynaecol. 2021 70 63 80 10.1016/j.bpobgyn.2020.06.011
Lotz L. Dittrich R. Hoffmann I. Beckmann M.W. Ovarian Tissue Transplantation: Experience from Germany and Worldwide Efficacy Clin. Med. Insights Reprod. Health 2019 13 1179558119867357 10.1177/1179558119867357
Salama M. Isachenko V. Isachenko E. Rahimi G. Mallmann P. Updates in preserving reproductive potential of prepubertal girls with cancer: Systematic review Crit. Rev. Oncol. Hematol. 2016 103 10 21 10.1016/j.critrevonc.2016.04.002
Khattak H. Malhas R. Craciunas L. Afifi Y. Amorim C.A. Fishel S. Silber S. Gook D. Demeestere I. Bystrova O. et al. Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: A systematic review and individual patient data meta-analysis Hum. Reprod. Update 2022 28 400 416 10.1093/humupd/dmac003 35199164
Gavish Z. Spector I. Peer G. Schlatt S. Wistuba J. Roness H. Meirow D. Follicle activation is a significant and immediate cause of follicle loss after ovarian tissue transplantation J. Assist. Reprod. Genet. 2018 35 61 69 10.1007/s10815-017-1079-z 29098533
Dolmans M.M. Martinez-Madrid B. Gadisseux E. Guiot Y. Yuan W.Y. Torre A. Camboni A. Van Langendonckt A. Donnez J. Short-term transplantation of isolated human ovarian follicles and cortical tissue into nude mice Reproduction 2007 134 253 262 10.1530/REP-07-0131 17660235
Amorim C.A. David A. Dolmans M.M. Camboni A. Donnez J. Van Langendonckt A. Impact of freezing and thawing of human ovarian tissue on follicular growth after long-term xenotransplantation J. Assist. Reprod. Genet. 2011 28 1157 1165 10.1007/s10815-011-9672-z 22105186
Terren C. Munaut C. Molecular Basis Associated with the Control of Primordial Follicle Activation During Transplantation of Cryopreserved Ovarian Tissue Reprod. Sci. 2021 28 1257 1266 10.1007/s43032-020-00318-z
Labied S. Delforge Y. Munaut C. Blacher S. Colige A. Delcombel R. Henry L. Fransolet M. Jouan C. Perrier d’Hauterive S. et al. Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation Transplantation 2013 95 426 433 10.1097/TP.0b013e318279965c
Henry L. Fransolet M. Labied S. Blacher S. Masereel M.C. Foidart J.M. Noel A. Nisolle M. Munaut C. Supplementation of transport and freezing media with anti-apoptotic drugs improves ovarian cortex survival J. Ovarian Res. 2016 9 4 10.1186/s13048-016-0216-0
Henry L. Labied S. Fransolet M. Kirschvink N. Blacher S. Noel A. Foidart J.M. Nisolle M. Munaut C. Isoform 165 of vascular endothelial growth factor in collagen matrix improves ovine cryopreserved ovarian tissue revascularisation after xenotransplantation in mice Reprod. Biol. Endocrinol. 2015 13 12 10.1186/s12958-015-0015-2
Tavana S. Valojerdi M.R. Azarnia M. Shahverdi A. Restoration of ovarian tissue function and estrous cycle in rat after autotransplantation using hyaluronic acid hydrogel scaffold containing VEGF and bFGF Growth Factors 2016 34 97 106 10.1080/08977194.2016.1194835
Kang B.J. Wang Y. Zhang L. Xiao Z. Li S.W. bFGF and VEGF improve the quality of vitrified-thawed human ovarian tissues after xenotransplantation to SCID mice J. Assist. Reprod. Genet. 2016 33 281 289 10.1007/s10815-015-0628-6
Arapaki A. Christopoulos P. Kalampokas E. Triantafyllidou O. Matsas A. Vlahos N.F. Ovarian Tissue Cryopreservation in Children and Adolescents Children 2022 9 1256 10.3390/children9081256
Dolmans M.M. Recent advances in fertility preservation and counseling for female cancer patients Expert. Rev. Anticancer Ther. 2018 18 115 120 10.1080/14737140.2018.1415758 29220203
Manavella D.D. Cacciottola L. Pomme S. Desmet C.M. Jordan B.F. Donnez J. Amorim C.A. Dolmans M.M. Two-step transplantation with adipose tissue-derived stem cells increases follicle survival by enhancing vascularization in xenografted frozen-thawed human ovarian tissue Hum. Reprod. 2018 33 1107 1116 10.1093/humrep/dey080 29635371
Manavella D.D. Cacciottola L. Desmet C.M. Jordan B.F. Donnez J. Amorim C.A. Dolmans M.M. Adipose tissue-derived stem cells in a fibrin implant enhance neovascularization in a peritoneal grafting site: A potential way to improve ovarian tissue transplantation Hum. Reprod. 2018 33 270 279 10.1093/humrep/dex374 29304240
Cacciottola L. Nguyen T.Y.T. Chiti M.C. Camboni A. Amorim C.A. Donnez J. Dolmans M.M. Long-Term Advantages of Ovarian Reserve Maintenance and Follicle Development Using Adipose Tissue-Derived Stem Cells in Ovarian Tissue Transplantation J. Clin. Med. 2020 9 2980 10.3390/jcm9092980 32942743
Cacciottola L. Courtoy G.E. Nguyen T.Y.T. Hossay C. Donnez J. Dolmans M.M. Adipose tissue-derived stem cells protect the primordial follicle pool from both direct follicle death and abnormal activation after ovarian tissue transplantation J. Assist. Reprod. Genet. 2021 38 151 161 10.1007/s10815-020-02005-z
Adib S. Valojerdi M.R. Alikhani M. Dose optimisation of PTEN inhibitor, bpV (HOpic), and SCF for the in-vitro activation of sheep primordial follicles Growth Factors 2019 37 178 189 10.1080/08977194.2019.1680661
Hu L.L. Su T. Luo R.C. Zheng Y.H. Huang J. Zhong Z.S. Nie J. Zheng L.P. Hippo pathway functions as a downstream effector of AKT signaling to regulate the activation of primordial follicles in mice J. Cell. Physiol. 2019 234 1578 1587 10.1002/jcp.27024 30078193
Roness H. Gavish Z. Cohen Y. Meirow D. Ovarian follicle burnout: A universal phenomenon? Cell Cycle 2013 12 3245 3246 10.4161/cc.26358
Masciangelo R. Hossay C. Donnez J. Dolmans M.M. Does the Akt pathway play a role in follicle activation after grafting of human ovarian tissue? Reprod. Biomed. Online 2019 39 196 198 10.1016/j.rbmo.2019.04.007
Hu L. Zaloudek C. Mills G.B. Gray J. Jaffe R.B. In Vivo and in Vitro Ovarian Carcinoma Growth Inhibition by a Phosphatidylinositol 3-Kinase Inhibitor (LY294002)1 Clin. Cancer Res. 2000 6 880 886
Kong H.S. Kim S.K. Lee J. Youm H.W. Lee J.R. Suh C.S. Kim S.H. Effect of Exogenous Anti-Mullerian Hormone Treatment on Cryopreserved and Transplanted Mouse Ovaries Reprod. Sci. 2016 23 51 60 10.1177/1933719115594021 26156852
Detti L. Fletcher N.M. Saed G.M. Sweatman T.W. Uhlmann R.A. Pappo A. Peregrin-Alvarez I. Xenotransplantation of pre-pubertal ovarian cortex and prevention of follicle depletion with anti-Mullerian hormone (AMH) J. Assist. Reprod. Genet. 2018 35 1831 1841 10.1007/s10815-018-1260-z 30043336
Celik S. Ozkavukcu S. Celik-Ozenci C. Recombinant anti-Mullerian hormone treatment attenuates primordial follicle loss after ovarian cryopreservation and transplantation J. Assist. Reprod. Genet. 2023 40 1117 1134 10.1007/s10815-023-02754-7
Xie Y. Li S. Zhou L. Lin H. Jiao X. Qiu Q. Liang Y. Zhang Q. Rapamycin preserves the primordial follicle pool during cisplatin treatment in vitro and in vivo Mol. Reprod. Dev. 2020 87 442 453 10.1002/mrd.23330
Jeon H.J. Lee H.E. Yang J. Safety and efficacy of Rapamune(R) (Sirolimus) in kidney transplant recipients: Results of a prospective post-marketing surveillance study in Korea BMC Nephrol. 2018 19 201 10.1186/s12882-018-1002-6
Zhang X.M. Li L. Xu J.J. Wang N. Liu W.J. Lin X.H. Fu Y.C. Luo L.L. Rapamycin preserves the follicle pool reserve and prolongs the ovarian lifespan of female rats via modulating mTOR activation and sirtuin expression Gene 2013 523 82 87 10.1016/j.gene.2013.03.039 23566837
Yorino S. Kawamura K. Rapamycin treatment maintains developmental potential of oocytes in mice and follicle reserve in human cortical fragments grafted into immune-deficient mice Mol. Cell. Endocrinol. 2020 504 110694 10.1016/j.mce.2019.110694 31887337
The Practice Committee of the American Society for Reproductive Medicine Ovarian tissue cryopreservation: A committee opinion Fertil. Steril. 2014 101 1237 1243 10.1016/j.fertnstert.2014.02.052
Terren C. Nisolle M. Munaut C. Pharmacological inhibition of the PI3K/PTEN/Akt and mTOR signalling pathways limits follicle activation induced by ovarian cryopreservation and in vitro culture J. Ovarian Res. 2021 14 95 10.1186/s13048-021-00846-5
Cheng Y. Kim J. Li X.X. Hsueh A.J. Promotion of ovarian follicle growth following mTOR activation: Synergistic effects of AKT stimulators PLoS ONE 2015 10 e0117769 10.1371/journal.pone.0117769 25710488
Lan C. Xiao W. Xiao-Hui D. Chun-Yan H. Hong-Ling Y. Tissue culture before transplantation of frozen-thawed human fetal ovarian tissue into immunodeficient mice Fertil. Steril. 2010 93 913 919 10.1016/j.fertnstert.2008.10.020
Van Eyck A.S. Jordan B.F. Gallez B. Heilier J.F. Van Langendonckt A. Donnez J. Electron paramagnetic resonance as a tool to evaluate human ovarian tissue reoxygenation after xenografting Fertil. Steril. 2009 92 374 381 10.1016/j.fertnstert.2008.05.012 18692811
Masciangelo R. Hossay C. Chiti M.C. Manavella D.D. Amorim C.A. Donnez J. Dolmans M.M. Role of the PI3K and Hippo pathways in follicle activation after grafting of human ovarian tissue J. Assist. Reprod. Genet. 2020 37 101 108 10.1007/s10815-019-01628-1 31732846
Behringer R. Mouse Ovary Transplantation Cold Spring Harb. Protoc. 2017 2017 3 10.1101/pdb.prot094458
Soleimani R. Van der Elst J. Heytens E. Van den Broecke R. Gerris J. Dhont M. Cuvelier C. De Sutter P. Back muscle as a promising site for ovarian tissue transplantation, an animal model Hum. Reprod. 2008 23 619 626 10.1093/humrep/dem405
Ayuandari S. Winkler-Crepaz K. Paulitsch M. Wagner C. Zavadil C. Manzl C. Ziehr S.C. Wildt L. Hofer-Tollinger S. Follicular growth after xenotransplantation of cryopreserved/thawed human ovarian tissue in SCID mice: Dynamics and molecular aspects J. Assist. Reprod. Genet. 2016 33 1585 1593 10.1007/s10815-016-0769-2
Ruan X. Cui Y. Du J. Jin J. Gu M. Chen S. Mueck A.O. Randomized study to prove the quality of human ovarian tissue cryopreservation by xenotransplantation into mice J. Ovarian Res. 2019 12 46 10.1186/s13048-019-0521-5
Garcia-Caballero M. Van de Velde M. Blacher S. Lambert V. Balsat C. Erpicum C. Durre T. Kridelka F. Noel A. Modeling pre-metastatic lymphvascular niche in the mouse ear sponge assay Sci. Rep. 2017 7 41494 10.1038/srep41494
Van de Velde M. Garcia-Caballero M. Durre T. Kridelka F. Noel A. Ear Sponge Assay: A Method to Investigate Angiogenesis and Lymphangiogenesis in Mice Methods Mol. Biol. 2018 1731 223 233 10.1007/978-1-4939-7595-2_20
Herrmann K. Flecknell P. Severity Classification of Surgical Procedures and Application of Health Monitoring Strategies in Animal Research Proposals: A Retrospective Review Altern. Lab. Anim. 2020 46 273 289 10.1177/026119291804600508
Terren C. Fransolet M. Ancion M. Nisolle M. Munaut C. Slow Freezing Versus Vitrification of Mouse Ovaries: From Ex Vivo Analyses to Successful Pregnancies after Auto-Transplantation Sci. Rep. 2019 9 19668 10.1038/s41598-019-56182-8 31873164
Gosden R.G. Baird D.T. Wade J.C. Webb R. Restoration of fertility to oophorectomized sheep by ovarian autografts stored at −196 degrees C Hum. Reprod. 1994 9 597 603 10.1093/oxfordjournals.humrep.a138556 8046009
Nicholson T.M. Uchtmann K.S. Valdez C.D. Theberge A.B. Miralem T. Ricke W.A. Renal capsule xenografting and subcutaneous pellet implantation for the evaluation of prostate carcinogenesis and benign prostatic hyperplasia J. Vis. Exp. 2013 78 e50574 10.3791/50574
Terren C. Bindels J. Nisolle M. Noel A. Munaut C. Evaluation of an alternative heterotopic transplantation model for ovarian tissue to test pharmaceuticals improvements for fertility restoration Reprod. Biol. Endocrinol. 2022 20 35 10.1186/s12958-022-00910-9
Myers M. Britt K.L. Wreford N.G. Ebling F.J. Kerr J.B. Methods for quantifying follicular numbers within the mouse ovary Reproduction 2004 127 569 580 10.1530/rep.1.00095
Grabinski N. Ewald F. Hofmann B.T. Staufer K. Schumacher U. Nashan B. Jucker M. Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells Mol. Cancer 2012 11 85 10.1186/1476-4598-11-85
Chen X.G. Liu F. Song X.F. Wang Z.H. Dong Z.Q. Hu Z.Q. Lan R.Z. Guan W. Zhou T.G. Xu X.M. et al. Rapamycin regulates Akt and ERK phosphorylation through mTORC1 and mTORC2 signaling pathways Mol. Carcinog. 2010 49 603 610 10.1002/mc.20628
Sulaimanov N. Klose M. Busch H. Boerries M. Understanding the mTOR signaling pathway via mathematical modeling Wiley Interdiscip. Rev. Syst. Biol. Med. 2017 9 e1379 10.1002/wsbm.1379
Celik S. Ozkavukcu S. Celik-Ozenci C. Altered expression of activator proteins that control follicle reserve after ovarian tissue cryopreservation/transplantation and primordial follicle loss prevention by rapamycin J. Assist. Reprod. Genet. 2020 37 2119 2136 10.1007/s10815-020-01875-7
Liu W. Zhang J. Wang L. Liang S. Xu B. Ying X. Li J. The protective effects of rapamycin pretreatment on ovarian damage during ovarian tissue cryopreservation and transplantation Biochem. Biophys. Res. Commun. 2021 534 780 786 10.1016/j.bbrc.2020.10.110
Chen X. Tang Z. Guan H. Xia H. Gu C. Xu Y. Li B. Zhang W. Rapamycin maintains the primordial follicle pool and protects ovarian reserve against cyclophosphamide-induced damage J. Reprod. Dev. 2022 68 287 294 10.1262/jrd.2022-001 35718464
Collins A.R. Ma A.G. Duthie S.J. The kinetics of repair of oxidative DNA damage (strand breaks and oxidised pyrimidines) in human cells Mutat. Res. 1995 336 69 77 10.1016/0921-8777(94)00043-6 7528897
Elvis-Offiah U.B. Isuman S. Johnson M.O. Ikeh V.G. Agbontaen S. Our Clear-Cut Improvement to the Impact of Mouse and Rat Models in the Research Involving Female Reproduction Animal Models and Experimental Research in Medicine InTechOpen London, UK 2023
Lee H.N. Chang E.M. Primordial follicle activation as new treatment for primary ovarian insufficiency Clin. Exp. Reprod. Med. 2019 46 43 49 10.5653/cerm.2019.46.2.43
Fujiwara M. Izuishi K. Sano T. Hossain M.A. Kimura S. Masaki T. Suzuki Y. Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells J. Exp. Clin. Cancer Res. 2008 27 76 10.1186/1756-9966-27-76 19032736
Al Shoyaib A. Archie S.R. Karamyan V.T. Intraperitoneal Route of Drug Administration: Should it Be Used in Experimental Animal Studies? Pharm. Res. 2019 37 12 10.1007/s11095-019-2745-x
